The team at DropGenie uses digital microfluidics to perform gene editing screens on small numbers of patient cells, accelerating the discovery of new drugs.
As scientific output grows, the risk of a promising drug getting lost increases, but advances in artificial intelligence and machine learning may prevent that.
Artificial intelligence is helping researchers fill in critical gaps in medical treatment by identifying new drug targets for more precision medicine solutions.